Recent Advances in Cardiovascular Pharmacology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Recent Advances in Cardiovascular Pharmacology PDF full book. Access full book title Recent Advances in Cardiovascular Pharmacology by William H. Frishman. Download full books in PDF and EPUB format.
Author: William H. Frishman
Publisher:
ISBN:
Category : Cardiovascular agents
Languages : en
Pages : 74
Get Book Here
Book Description
Author: William H. Frishman
Publisher:
ISBN:
Category : Cardiovascular agents
Languages : en
Pages : 74
Get Book Here
Book Description
Author: Australasian Society of Clinical and Experimental Pharmacologists
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Y. Robert Li
Publisher: John Wiley & Sons
ISBN: 0470915374
Category : Medical
Languages : en
Pages : 501
Get Book Here
Book Description
Written in an accessible style and consistent format, the book covers both the fundamentals and advances in the pharmacology of cardiovascular drugs, as well as their integrated applications in the management of individual cardiovascular diseases. • Integrates fundamentals and recent advances regarding cardiovascular drugs, blending basic and clinical sciences needed to effectively understand and treat cardiovascular diseases • Facilitates understanding of drug action and mechanism by covering physiology / pathophysiology and pharmacology • Includes guidelines and algorithms for pharmacotherapeutic management of cardiovascular diseases • Uses case presentations and study questions to enhance understanding of the material • Serves as a resource for pharmaceutical and medical students and researchers interested in cardiovascular issues
Author: Kanu Chatterjee
Publisher: JAYPEE BROTHERS PUBLISHERS
ISBN: 9350907798
Category : Medical
Languages : en
Pages : 529
Get Book Here
Book Description
Doody Rating : 3 stars : Cardiac drugs resource endows with the latest advances in cardiovascular pharmacology. Written by experts in cardiology from world renowned institutes, equipped with global view, signifying the best possible combination of clinical and research expertise in cardiovascular pharmacology. This is a comprehensive drug resource which provides up-to-date information on one of the most rapidly changing areas of medicine. Easy to follow, providing practical advice on how to manage cardiac diseases with a focus on hands-on therapeutic guidance for the clinicians. Text talks about all of the drug-groups useful in various indications like drugs for acute coronary syndromes, dyslipidemia, hypertension, pulmonary hypertension, angina, etc. along with data from clinical trials. This book is exhaustive coverage of newly evolving co-morbid conditions with chapters on metabolic syndrome and pregnancy. Future directions: Pharmacogenomics elaborates on gene interactions with cardiovascular drugs. The unique feature of this book is the detailed discussion on the guidelines of the American College of Cardiology/American Heart Association for the use of pharmacologic agents in various clinical conditions. It is enhanced with four colour illustrations and images, illustrating the key pharmacological and physiological actions. It is useful for cardiologist, pharmacologist, physicians, clinicians and specialist.
Author: Philippe R. Housmans
Publisher:
ISBN:
Category : Cardiovascular agents
Languages : en
Pages : 280
Get Book Here
Book Description
Author: William H. Frishman, MD
Publisher: Cardiotext Publishing
ISBN: 1935395629
Category : Medical
Languages : en
Pages : 798
Get Book Here
Book Description
Everything practicing physicians and pharmacists need to know about drug therapy for cardiovascular disease. A critically acclaimed classic reference now in its third edition, Cardiovascular Pharmacotherapeutics provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such therapies in cardiac disease, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states. This new third edition presents an in-depth discussion of: All cardiovascular agents currently available The scientific basis behind every pharmacotherapy advance Mechanisms of action of cardiovascular pharmacotherapeutics The latest advances in cardiovascular drug therapy Specific drug treatments, and information on recently approved drugs Molecular biological advances Drugs in development Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease Also included are 8 appendices that provide practical, hands-on information on using drugs in clinical settings, including relevant pharmacokinetic information, and practical drug prescribing information. All updated with an accompanying website, Advances in Cardiovascular Pharmacotherapeutics www.cvpct3.com
Author: Deepak L. Bhatt
Publisher: Elsevier Health Sciences
ISBN: 0323673627
Category : Medical
Languages : en
Pages : 723
Get Book Here
Book Description
Authoritative, portable, and up to date, Opie’s Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients. Now a part of the Braunwald family of renowned cardiology references, this compact title provides crucial information in an easily accessible format—ideal for cardiologists, residents, cardiology fellows, medical students, nurses, and other cardiac care providers. Updated to include the latest guidelines and evidence-based implications, it offers clear and concise explanations and pertinent clinical facts for all classes of cardiac drugs, as well as all the latest clinical trial results and evidence for the pharmacologic treatment of heart disease. Uses a new, consistent format for each drug class: overview and guidelines for use, mechanisms of action, differences among drugs in class, data for use, side effects, and drug interactions. Covers key topics such as new ESC and NLA guidelines, advances in lipid-lowering therapy, new diabetes drugs that improve cardiovascular outcomes, obesity drugs and cardiovascular and metabolic effects, drugs targeting inflammation, and combinations of antithrombotic therapies with analysis of risk-benefit. Provides guidance on how to effectively manage comorbid diseases. Contains dozens of unique “Opiegram diagrams that demystify complex mechanisms of action and other drug processes—many updated to reflect current pathologic understanding of mechanisms.
Author: Lionel H. Opie
Publisher: Elsevier Health Sciences
ISBN: 1455740896
Category : Medical
Languages : en
Pages : 513
Get Book Here
Book Description
The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on the practical use of drugs saves you valuable time in researching relevant information. Features the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Offers easy-to-access, useful information on when to use each drug—and for what conditions—in a chapter entitled “Which Drug for Which Disease. Discusses the management of single diseases and multiple comorbidities. Summarizes each drug class at the end of chapters to expedite reference. Incorporates all-new drugs, preparations, and clinical trial data in each chapter, equipping you to make the most up-to-date, informed clinical decisions. Offers expanded coverage of comorbid diseases through new chapters on metabolic syndrome, hyperglycemia, and diabetes. Features an increased emphasis on the practical use of drugs through highlighted sections and key illustrations, saving you time in searching for relevant information. Presents the work of several new contributors who represent a broad international perspective to equip you with a global view of cardiovascular pharmacology.
Author: JoAnn E. Manson
Publisher: Oxford University Press, USA
ISBN:
Category : Language Arts & Disciplines
Languages : en
Pages : 592
Get Book Here
Book Description
Coronary heart disease remains the leading cause of death in both men and women in most industrialized countries. Yet it is largely preventable, and health care providers can acquire the skills to help their patients reduce their risks substantially. Traditional risk factors such as cigarette smoking, hypercholesterolimia, hypertension, sedentary lifestyle, obesity and glucose intolerance explain a major proportion of coronary events. Recent evidence also suggests important adjunctive roles for hormone replacement therapy in postmenopausal women, and aspirin prophlaxis in individuals at high risk of a first myocardial infarction. Emerging evidence indicates an important role for diet in the prevention of heart disease. Although the importance of lifestyle and behavioral modifications may well be known among physicians and other health-care providers, the implementation of this knowledge has been limited. One reason is that the information supporting the value, feasibility and cost-effectiveness of risk-reduction strategies has not been previously synthesized and made widely available to health-care providers in office and community settings. Prevention of Myocardial Infarction fills these critical gaps by providing a state-of-the-art compendium of the scientific evidence on the efficacy of coronary disease prevention, while focusing on helping clinicians develop intervention skills to utilize available knowledge. Chapters by leading authorities in cardiovascular epidemiology, clinical cardiology, cost-effectiveness analysis, and public health translate the theory of preventive cardiology into feasible implementation. The counseling and other intervention strategies described in this textbook have documented clinical efficacy and cost-effectiveness, and they require little time to learn or implement. The book is written mainly for primary care providers, including general internists and family physicians, but will also be of interest to medical subspecialties such as cardiologists and endocrinologists, as well as medical students, dietitians, psychologists, epidemiologists, and students, practitioners, and researchers in public health.
Author: Gowraganahalli Jagadeesh
Publisher: Springer
ISBN: 3319159615
Category : Medical
Languages : en
Pages : 1323
Get Book Here
Book Description
The present book covers the basic principles of cardiovascular physiology, pathophysiology and advanced pharmacology with particular emphasis on cellular mechanisms of drug action. It provides an update on the progress made in several aspects of cardiovascular diseases so that it might kindle scientists and clinicians alike in furthering basic and translational research. In addition, the book is expected to fill imperative gaps in understanding and optimally treating cardiovascular disease.
